SCHEMBL2900429

SCHEMBL2900429

Cc1n[nH]cc1-c1nc(N2CCOC[C@@H]2C)c2ccc(-c3cccc(CO)c3)nc2n1

nearest known ligand 0.73

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MTOR P42345 20/20 0.73

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2903547 0.85 MTOR (1.00) MTOR
SCHEMBL10224930 0.84 MTOR (1.00) MTOR
SCHEMBL2925208 0.84 MTOR (1.00) MTOR
SCHEMBL4172225 0.83 MTOR (1.00) MTOR
SCHEMBL2900196 0.83 MTOR (1.00) MTOR
SCHEMBL2906195 0.83 MTOR (1.00) MTOR
SCHEMBL393909 0.83 MTOR (0.83) MTOR
SCHEMBL393908 0.83 MTOR (0.83) MTOR
SCHEMBL2900427 0.83 MTOR (1.00) MTOR
SCHEMBL2900697 0.81 MTOR (1.00) MTOR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2217234-A2 COMBINATIONS OF MEK INHIBITORS WITH MTOR INHIBITORS AstraZeneca AB (SE) 2010-08-18 EP disclosed
WO-2009050506-A2 COMBINATION 059 ASTRAZENECA AB (SE) 2009-04-23 WO disclosed